PE20010752A1 - Uso de desloratadina para el tratamiento de estados alergicos e inflamatorios - Google Patents

Uso de desloratadina para el tratamiento de estados alergicos e inflamatorios

Info

Publication number
PE20010752A1
PE20010752A1 PE2000000969A PE0009692000A PE20010752A1 PE 20010752 A1 PE20010752 A1 PE 20010752A1 PE 2000000969 A PE2000000969 A PE 2000000969A PE 0009692000 A PE0009692000 A PE 0009692000A PE 20010752 A1 PE20010752 A1 PE 20010752A1
Authority
PE
Peru
Prior art keywords
desloratadine
allergic
treatment
inflammatory states
day
Prior art date
Application number
PE2000000969A
Other languages
English (en)
Inventor
Kim Allen Heithoff
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of PE20010752A1 publication Critical patent/PE20010752A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/16Otologicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents

Abstract

SE REFIERE AL USO DE DESLORATADINA PARA LA PREPARACION DE UN MEDICAMENTO UTILIZANDO 2,5mg/dia A 45mg/dia, PARA EL TRATAMIENTO DE UN ESTADO ALERGICO Y/O INFLAMATORIO DE LA PIEL O VIAS RESPIRATORIAS
PE2000000969A 1999-09-22 2000-09-19 Uso de desloratadina para el tratamiento de estados alergicos e inflamatorios PE20010752A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US40059999A 1999-09-22 1999-09-22

Publications (1)

Publication Number Publication Date
PE20010752A1 true PE20010752A1 (es) 2001-07-17

Family

ID=23584252

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2000000969A PE20010752A1 (es) 1999-09-22 2000-09-19 Uso de desloratadina para el tratamiento de estados alergicos e inflamatorios

Country Status (7)

Country Link
EP (1) EP1214071A2 (es)
JP (1) JP2003509459A (es)
AR (1) AR025724A1 (es)
AU (1) AU7589700A (es)
CA (1) CA2383214A1 (es)
PE (1) PE20010752A1 (es)
WO (1) WO2001021162A2 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7405223B2 (en) 2000-02-03 2008-07-29 Schering Corporation Treating allergic and inflammatory conditions

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1985003707A1 (en) * 1984-02-15 1985-08-29 Schering Corporation 8-CHLORO-6,11-DIHYDRO-11-(4-PIPERIDYLIDENE)-5H-BENZO AD5,6 BDCYCLOHEPTA AD1,2-b BDPYRIDINE AND ITS SALTS, PROCESSES FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS
US5595997A (en) * 1994-12-30 1997-01-21 Sepracor Inc. Methods and compositions for treating allergic rhinitis and other disorders using descarboethoxyloratadine
WO1998006394A1 (en) * 1996-08-16 1998-02-19 Schering Corporation Treatment of upper airway allergic responses with a combination of histamine receptor antagonists
TW522014B (en) * 1997-02-07 2003-03-01 Sepracor Inc Lactose-free, non-hygroscopic and anhydrous pharmaceutical unit dosage form containing descarboethoxyloratadine
US5900421A (en) * 1997-02-11 1999-05-04 Sepracor Inc. Methods and compositions for treating allergic asthma and dermatitis using descarboethoxyloratadine
AU2407597A (en) * 1997-04-25 1998-11-24 Schering-Plough Kabushiki Kaisha Eyedrops

Also Published As

Publication number Publication date
AR025724A1 (es) 2002-12-11
WO2001021162A2 (en) 2001-03-29
EP1214071A2 (en) 2002-06-19
AU7589700A (en) 2001-04-24
CA2383214A1 (en) 2001-03-29
JP2003509459A (ja) 2003-03-11
WO2001021162A3 (en) 2002-03-07

Similar Documents

Publication Publication Date Title
DOP2002000429A (es) Imidazotriazinas
ECSP045081A (es) Derivados de 1,8-naftiridina y su uso para el tratamiento de la diabetes y trastornos relacionados
AR023972A1 (es) Composiciones de medicamentos a base de compuestos anticolinergicamente activos y beta-mimeticos
BR0213358A (pt) Uso de flibanserina
DK1404331T3 (da) Sustained release-formuleringer af oxymorphon
AR028372A1 (es) Dispositivos de administracion de drogas de liberacion sostenida, metodos de uso y metodos de fabricacion de los mismos
PT1757606E (pt) Utilização de derivados de xantina como produto farmacêutico, bem como seu processo de preparação
BR0309544A (pt) Preparação farmacêutica contendo oxicodona e naloxona
CO5050297A1 (es) Uso de peg-ifn-alfa y ribavirina para el tratamiento de hepatitis c cronica
EE04939B1 (et) Arlmetlkarbonlaminotiasooli derivaadid, nende valmistamine ja kasutamine v„hivastaste toimeainetena
EA200301165A1 (ru) Лекарственное средство на основе оксикодона
FI4823U1 (fi) Muunnetulla tavalla vapauttava lääkeformulaatio
FR2866884B1 (fr) Derives d'aryl-et d'heteroaryl-piperidinecarboxylates, leur preparation et leur application en therapeutique
AR025883A1 (es) Utilizacion de antagonistas de los receptores de los cannabinoides centrales para la preparacion de medicamentos
UY27455A1 (es) Derivados n-(1,4,5,6-tetrahidro-ciclopentapirazol -3-il)- sustituidos. su obtención y uso como fármacos.
EE200100470A (et) Püridopüranoasepiini derivaadid, nende valmistamine ja terapeutiline kasutamine
PE20010623A1 (es) Uso de (+)-tramadol y/o o-demetiltramadol para tratamiento de urgencia urinaria incrementada y/o incontinencia urinaria
EP1440689A3 (en) Treatment of neurotic disorders
AU2000255628A1 (en) Formulation comprising thymol useful in the treatment of drug resistant bacterial infections
EE05241B1 (et) Distamtsiini a-halogenoakrlolderivaadi kasutamine
BR0210632A (pt) Tratamento de doença parasìtica
FR2873693B1 (fr) Derives d'amino-tropane, leur preparation et leur application en therapeutique
HUP0204208A2 (hu) Pruritus kezelésére szolgáló külsőleges gyógyszerkészítmény
PE20010752A1 (es) Uso de desloratadina para el tratamiento de estados alergicos e inflamatorios
BR0210910A (pt) Derivados de imidazotriazinonas e sua aplicação contra processos inflamatórios e/ou doenças imunes

Legal Events

Date Code Title Description
FC Refusal